These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16616963)

  • 1. The number needed to treat in cardiovascular clinical trials.
    Curiel R; Rodríguez-Plaza L
    Int J Cardiol; 2007 Jan; 114(3):388-9. PubMed ID: 16616963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.
    Hutton JL
    Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the validity and utility of randomized clinical trials in addictions treatment research: II. Participant samples and assessment.
    Del Boca FK; Darkes J
    Addiction; 2007 Aug; 102(8):1194-203. PubMed ID: 17511752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Critical assessment of articles on controlled clinical trials II. Results].
    Ferreira JJ; Sampaio C
    Acta Med Port; 1998; 11(8-9):755-60. PubMed ID: 9951068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observational research: a fundamental tool for clinical practice].
    Tavazzi L; Tognoni G; Maggioni AP
    Ital Heart J Suppl; 2005 Oct; 6(10):682-9. PubMed ID: 16273756
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing outcomes on peritoneal and hemodialysis: a case study in the interpretation of observational studies.
    Davies SJ
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):24-30. PubMed ID: 17237887
    [No Abstract]   [Full Text] [Related]  

  • 8. Confidence intervals for the number needed to treat. Absolute risk reduction is less likely to be misunderstood.
    Newcombe RG
    BMJ; 1999 Jun; 318(7200):1765-7. PubMed ID: 10428570
    [No Abstract]   [Full Text] [Related]  

  • 9. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The several faces of clinical trials: from new therapies to failed preventive strategies.
    Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):173. PubMed ID: 16568110
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
    Bernardi G; Morocutti G; Spedicato L; Zanuttini D
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on "a review of the trials comparing carotid endarterectomy and carotid angioplasty and stenting".
    Oderich GS
    Perspect Vasc Surg Endovasc Ther; 2008 Sep; 20(3):309-10. PubMed ID: 18930942
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective randomized trials in clinical research.
    Wolfe BM; Mathieseu KA
    Surg Endosc; 1995 Nov; 9(11):1214-6. PubMed ID: 8553239
    [No Abstract]   [Full Text] [Related]  

  • 15. Does analysis using "last observation carried forward" introduce bias in dementia research?
    Molnar FJ; Hutton B; Fergusson D
    CMAJ; 2008 Oct; 179(8):751-3. PubMed ID: 18838445
    [No Abstract]   [Full Text] [Related]  

  • 16. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 17. High risk and unfit for open repair are not the same.
    Greenhalgh RM; Brown LC; Powell JT
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):154-5. PubMed ID: 17574879
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
    ; Devereaux PJ; Yang H; Guyatt GH; Leslie K; Villar JC; Monteri VM; Choi P; Giles JW; Yusuf S
    Am Heart J; 2006 Aug; 152(2):223-30. PubMed ID: 16875901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluating treatment effect].
    Lindh J
    Lakartidningen; 2013 Jan 23-29; 110(4):159-62. PubMed ID: 23427725
    [No Abstract]   [Full Text] [Related]  

  • 20. Reliable evidence of safety and efficacy of elderly patients in randomized clinical trials still needed.
    Crean SM; Reynolds MW; Dematto CA
    J Clin Oncol; 2007 Sep; 25(25):4027-8; author reply 4028. PubMed ID: 17761994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.